A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia In T2DM
NCT01523405 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4911
Last updated 2014-09-08
Summary
This is a non-interventional, cross sectional, multicentric study in T2DM patients which will involve a single visit for study related procedures. This study will be conducted in approximately 5,000 patients at around 300 hospitals/primary care clinics across India. Approximately 18-20 patients per site will be enrolled. This study has been designed to evaluate diabetes related quality of life (DQoL), frequency and impact of hypoglycaemia in relation to HbA1c control and to assess disease modifying variables-BMI and BP in T2DM patients on oral / injectable anti-diabetic drugs with/without insulin therapy.
Conditions
- Type II Diabetes Mellitus
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Abhay Raut, MD · Prashanti Clinic,
-
Sashi Kumar, MBBS · Dianova Diabetes Centre
-
Subodh Chandra, MD · Chandra Medicals Pvt. Ltd
-
Debashish Maji, MD, DM · Calcutta Diabetes and endocrine Foundation,
-
Mayur Patel, MD · Swasthya (All India Institute of Diabetes and Research)
-
Nallaperumal Sivagnam, MBBS · Swamy Diabetes Centre,
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2013-02-28
- Completion
- 2013-02-28
Countries
- India
Study Locations
More Related Trials
-
Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes Mellitus
NCT03042325 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus
NCT02175784 ·Status: COMPLETED ·Phase: PHASE4
-
To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Metformin
NCT00774553 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus
NCT05158244 ·Status: COMPLETED ·Phase: PHASE1
-
A Study for Sufficient Acarbose Decreased Glucose Excursion in Type 2 Diabetic Patients
NCT03805191 ·Status: UNKNOWN
-
A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients
NCT00336310 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 Diabetes
NCT00856908 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone
NCT01257412 ·Status: SUSPENDED ·Phase: PHASE3
-
To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Insulin
NCT00768105 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin
NCT04233801 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone
NCT00970424 ·Status: TERMINATED ·Phase: PHASE3
-
To Study Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1656 in Japanese Type 2 Diabetes Mellitus (T2DM) Patients
NCT00916604 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.
NCT03848793 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase Ib Study of AZD5004 in Chinese Participants With Overweight/Obesity With or Without Type 2 Diabetes Mellitus
NCT06988553 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes
NCT04591626 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of HS-20094 in Healthy Participants
NCT05116410 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects
NCT00162305 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and Sulfonylurea
NCT00995787 ·Status: COMPLETED ·Phase: PHASE1
-
Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)
NCT02291874 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus
NCT01294436 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Dapagliflozin on Glycemic Variability
NCT02459353 ·Status: COMPLETED ·Phase: PHASE4
-
Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients
NCT00461617 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus
NCT01294423 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses
NCT00841048 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus
NCT00286442 ·Status: COMPLETED ·Phase: PHASE3